spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  INSPIRE trial 

 HSMN NewsFeed - 12 Apr 2018
TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation
Devices Surgery FDA
 HSMN NewsFeed - 26 May 2016
TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy
Devices Venture Capital
 HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Feb 2011
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 May 2010
For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Mar 2010
Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jan 2010
IRX Therapeutics Appoints Neil L. Berinstein Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2009
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Mar 2007
InterMune Updates Expense Forecasts and Development Plans
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2007
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2006
InterMune Closes Collaboration Agreement With Roche
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Apr 2006
InterMune Initiates Phase III Program Evaluating Pirfenidone in Patients With IPF
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2006
InterMune Completes Enrollment of the Phase III INSPIRE Trial
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2006
InterMune Discontinues Ovarian Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jan 2006
InterMune Completes Divestiture of Infergen(R) for up to $135.5 Million in Cash
Biopharmaceuticals Acquisitions
Return to NewsFeed  

 Additional items found! 21

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 21 additional stories matching:
INSPIRE trial
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.